威尔逊病肌病:一个病例报告和简要文献评论
Nicholas M Riccione1, Cassie N Chan1
1Neurology, University of Texas Health Science Center at San Antonio, San Antonio, USA.
Cureus
|January 19, 2026
概括
威尔逊病是一种遗传性铜毒性疾病,可以表现为外围肌肉病变. 即使症状异常,早期诊断至关重要,以有效管理这种罕见的疾病.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 毒理学 毒理学 毒理学
背景情况:
- 威尔逊病是一种罕见的遗传性疾病,其特征是过度积聚铜.
- 它通常会影响多个器官,中枢神经系统的参与是最常见的.
- 外围神经肌肉症状很少被报告为主要呈现特征.
研究的目的:
- 报告一个肌肉病的病例作为威尔逊病的初始表现.
- 审查关于威尔逊病的肌肉骨表现的文献.
- 要强调考虑威尔逊病在特异性外围肌肉病变症中的重要性.
主要方法:
- 一个37岁的男性的病例报告,经历了复杂的诊断过程.
- 对类似病例的文献综述和建议的病理生理机制.
- 巩固当前关于威尔逊病相关肌肉骨症状的知识.
主要成果:
- 在经过一项具有挑战性的诊断过程后,对威尔逊病的二次肌肉病的诊断得到了确立.
- 在文献综述中,发现了稀少但重要的关于威尔逊病中外围神经肌肉参与的报道.
- 这一案例强调了非典型呈现所带来的诊断挑战.
结论:
- 威尔逊病应考虑在异形外围肌肉病的差异诊断.
- 在患有不明原因肌肉病的患者中识别威尔逊病对于及时干预至关重要.
- 巩固并发症可以帮助识别威尔逊病作为潜在原因.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Disorders of the Skeletal Muscle
2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myocarditis II: Clinical Features and Diagnostic Tests
493
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53


